Identification | More | [Name]
(R)-(-)-Glycidyl nosylate | [CAS]
115314-17-5 | [Synonyms]
(2R)-(-)-GLYCIDYL-3-NITROBENZENESULFONATE 3-NITROBENZENESULFONIC ACID (R)-GLYCIDYL ESTER BENZENESULFONIC ACID, 3-NITRO-, (2R)-OXIRANYLMETHYL ESTER (R)-2,3-EPOXY-1-PROPYL-3-NITROBENZENESULFONATE (R)-(-)-GLYCIDYL-3-NITROBENZENESULFONATE (R)-GLYCIDYL 3-NITROBENZENESULFONATE (R)-(-)-GLYCIDYL-3-NOSYLATE (R)-(-)-GLYCIDYL NOSYLATE (R)-GLYCIDYL NOSYLATE (R)-(-)-OXIRANE-2-METHANOL 3-NITROBENZENESULFONATE 3-nitro-,oxiranylmethylester,(r)-benzenesulfonicaci oxiranylmethyl(r)-3-nitrobenzenesulfonate (2R)-(-)-Glycidyl-3-nitrobenzenesulphonate (2R)-(-)-GLYCIDYL 3-NITROBENZENE- R-Glycidyl-3-Nitrobenzenesulfo (R)-(-)-GLYCIDYL3-NITRO-BENZENESULPHONATE BENZENESULFONIC ACID, 3-NITRO-(2R)-2-OXIRANYL-METHYL ESTER (R)-(-)-Glycidyl 3-nitrobenzenesulfonate, (R)-(-)-Oxirane-2-methanol 3-nitrobenzenesulfonate [(2R)-Oxiran-2-yl]methyl 3-nitrobenzenesulfonate Benzenesulfonic acid, 3-nitro-, oxiranylmethyl ester, (R) | [EINECS(EC#)]
601-353-9 | [Molecular Formula]
C9H9NO6S | [MDL Number]
MFCD00013436 | [Molecular Weight]
259.24 | [MOL File]
115314-17-5.mol |
Chemical Properties | Back Directory | [Appearance]
white to light yellow crystal powde | [Melting point ]
59-63 °C
| [alpha ]
-21.5 º (c=2, CHCl3) | [Boiling point ]
432.2±20.0 °C(Predicted) | [density ]
1.5881 (rough estimate) | [refractive index ]
1.5270 (estimate) | [storage temp. ]
-20°C | [solubility ]
Chloroform (Slightly), DMSO (Slightly) | [form ]
Crystalline Needles or Powder | [color ]
Slightly yellow | [Optical Rotation]
-22.001°(C=1.00 g/100ml, CHCL3) | [InChI]
InChI=1S/C9H9NO6S/c11-10(12)7-2-1-3-9(4-7)17(13,14)16-6-8-5-15-8/h1-4,8H,5-6H2/t8-/m1/s1 | [InChIKey]
AIHIHVZYAAMDPM-MRVPVSSYSA-N | [SMILES]
C1(S(OC[C@H]2CO2)(=O)=O)=CC=CC([N+]([O-])=O)=C1 | [CAS DataBase Reference]
115314-17-5(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S37/39:Wear suitable gloves and eye/face protection . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36:Wear suitable protective clothing . | [RIDADR ]
UN 1325 4.1/PG II | [RTECS ]
DB7192000 | [HazardClass ]
4.1 | [PackingGroup ]
II | [HS Code ]
29209090 |
Hazard Information | Back Directory | [Chemical Properties]
white to light yellow crystal powde | [Uses]
(R)-(-)-Glycidyl Nosylate (cas# 115314-17-5) is a compound useful in organic synthesis. | [Synthesis]
Preparation of Compound 3: To an anhydrous dichloromethane (10 mL) and triethylamine (1.5 mL, 10 mmol) solution of (S)-oxiran-2-ylmethanol (220 mg, 3.0 mmol) that had been cooled to 0 °C (ice bath), 3-nitrobenzenesulfonyl chloride (730 mg, 3.3 mmol) was added in batches. The resulting brown solution was stirred at 0 °C for 1 h, followed by slow warming to room temperature. The progress of the reaction was monitored by TLC every 15 min until (S)-oxiran-2-ylmethanol was completely consumed. Upon completion of the reaction, the reaction was quenched by the addition of crushed ice (1-2 g). The reaction mixture was transferred to a dispensing funnel and partitioned with dichloromethane (20 mL) and water (10 mL). The organic layer was washed sequentially with saturated aqueous NaHCO3 (10 mL x 3) and brine (10 mL x 3), followed by drying with anhydrous Na2SO4. After filtration and concentration, the residue was purified by fast column chromatography to afford (S)-(+)-m-nitrobenzenesulfonic acid glycidyl ester (Compound 3) as a brown solid (710 mg, 92%).1H NMR (400 MHz, CDCl3) δ 8.77 (s, 1H), 8.54 (d, J=8.1 Hz, 1H), 8.28 (d, J=7.9 Hz , 1H), 4.50 (d, J=11.5Hz, 1H), 4.04 (dd, J1=4.9Hz, J2=1.5Hz, 1H), 3.23 (d, J=1.8Hz, 1H), 2.85 (dd, J1=4.0Hz, J2=2.0Hz, 1H), 2.64 (dd, J1=2.4Hz, J2=2.0Hz, 1H) 1H); 13C NMR (100 MHz, CDCl3) δ 148.19, 137.92, 133.32, 130.81, 128.39, 123.16, 71.69, 48.64, 44.42. | [References]
[1] Patent: US2009/182011, 2009, A1. Location in patent: Page/Page column 13 [2] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 9, p. 656 - 661 [3] Tetrahedron, 2009, vol. 65, # 31, p. 5984 - 5989 [4] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2948 - 2950 [5] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 17, p. 4792 - 4802 |
|
|